Orange Book product · Generic (ANDA)
NORTRIPTYLINE HYDROCHLORIDE
NORTRIPTYLINE HYDROCHLORIDE
At a glance
Feb 24, 2021
Approved
Generic (ANDA)
Application
Not listed
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Feb 24, 2021
5 yr 5 mo ago
Today
Pharmaceutical detail
Active ingredient
NORTRIPTYLINE HYDROCHLORIDE
Strength
EQ 10MG BASE
Dosage form
CAPSULE
Route
ORAL
TE code
Not listed
Application
ANDA 213441
Product number
001
Marketing status
DISCN
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of NORTRIPTYLINE HYDROCHLORIDE
- —AVENTYL HYDROCHLORIDEBrand (NDA)
NDA 014684 · LILLY
- —PAMELORBrand (NDA)
NDA 018013 · SPECGX LLC
- —AVENTYLBrand (NDA)
NDA 014685 · RANBAXY
- —PAMELORBrand (NDA)
NDA 018012 · SPECGX LLC
- 2023NORTRIPTYLINE HYDROCHLORIDEGeneric (ANDA)
ANDA 217731 · RUBICON RESEARCH
- 2006NORTRIPTYLINE HYDROCHLORIDEGeneric (ANDA)
ANDA 077965 · TARO
- 2000NORTRIPTYLINE HYDROCHLORIDEGeneric (ANDA)
ANDA 075606 · PHARM ASSOC
- 2000NORTRIPTYLINE HYDROCHLORIDEGeneric (ANDA)
ANDA 075520 · TARO
- 1997NORTRIPTYLINE HYDROCHLORIDEGeneric (ANDA)
ANDA 074835 · AUROBINDO PHARMA LTD
- 1996NORTRIPTYLINE HYDROCHLORIDEGeneric (ANDA)
ANDA 073667 · TEVA
- 1995NORTRIPTYLINE HYDROCHLORIDEGeneric (ANDA)
ANDA 074132 · TEVA
- 1993NORTRIPTYLINE HYDROCHLORIDEGeneric (ANDA)
ANDA 074234 · RISING
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
